LI
AMAG

Leap Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

Leap Investments’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-26,533
Closed -$323K – 665
2019
Q4 		$323K Buy
+26,533
New +$290K 0.15% 231
2019
Q3 		– Sell
-69,000
Closed -$689K – 548
2019
Q2 		$689K Buy
+69,000
New +$744K 0.93% 16

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Leap Investments's AMAG Position: Q1 2020 in Review

Leap Investments sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 26,533 shares — an estimated $323K sold.

Leap Investments first reported a position in AMAG in Q2 2019 and held it in 2 quarters. The position peaked at $689K in Q2 2019. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • Leap Investments reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Leap Investments sold 26,533 AMAG Pharmaceuticals shares in Q1 2020, an estimated $323K.
  • Leap Investments first reported a position in AMAG Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Leap Investments's AMAG Pharmaceuticals position peaked at $689K in Q2 2019.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.